Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
•
Hospital Medicine
How do you manage recurrent C diff which occurs shortly after FMT when alternate etiologies of diarrhea have been excluded and patient is responding to C diff-directed therapies?
Related Questions
Under what circumstances do you consider valacyclovir for the management of VZV disease of the CNS?
What workup is sufficient to determine if an aortic aneurysm is "mycotic/infectious" or not, in that you would not prescribe empiric antibiotic therapy?
Does your hospital or institution have an Antimicrobial Stewardship Program (ASP), which oversees ID physicians, and if so, does the ASP have the authority to refuse an antibiotic prescribed by an ID consultant?
What is your recommendation for timing of urgent chemotherapy in patients with staph aureus bacteremia or endocarditis who require prolonged durations?
Do you routinely perform echocardiography in patients with Staphylococcus aureus bacteremia deemed low risk for metastatic infection, or do you selectively omit it based on specific clinical criteria?
When should antibiotics be discontinued for an immunocompetent patient with signs of meningoencephalitis who undergoes an LP without prior administration of antibiotics and the CSF shows a neutrophilic pleocytosis, negative Gram stain, negative PCR Panel, and negative CSF culture at day 3-5?
What is your preferred agent and duration to treat an epidural abscess due to azole-resistant candida species?
Are there situations where you would consider treating E faecalis or E faecium that grows from a respiratory culture?
What is your approach to managing antimicrobial therapy for intra-abdominal infections to avoid unnecessary double anaerobic coverage, in light of associated risks and guidelines?
Would you still consider adding clindamycin for streptococcal toxic shock syndrome in situations where the isolate is considered to be resistant?
